• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

COVID-19 in Qatar: Ways forward in public health and treatment.

作者信息

van Teijlingen Edwin, Sathian Brijesh, Simkhada Padam, Banerjee Indrajit

机构信息

Department of Pharmacology, Sir Seewoosagur Ramgoolam Medical College, Belle Rive, Vacoas-Phoenix, Mauritius.

出版信息

Qatar Med J. 2021 Jan 4;2020(3):38. doi: 10.5339/qmj.2020.38. eCollection 2020.

DOI:10.5339/qmj.2020.38
PMID:33447537
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7780299/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d75/7780299/d432ce124a18/qmj-2020-038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d75/7780299/ef41b5cc9c5e/qmj-2020-038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d75/7780299/d432ce124a18/qmj-2020-038-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d75/7780299/ef41b5cc9c5e/qmj-2020-038-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5d75/7780299/d432ce124a18/qmj-2020-038-g002.jpg

相似文献

1
COVID-19 in Qatar: Ways forward in public health and treatment.卡塔尔的新冠肺炎疫情：公共卫生与治疗的未来之路
Qatar Med J. 2021 Jan 4;2020(3):38. doi: 10.5339/qmj.2020.38. eCollection 2020.
2
Qatar, the Coronavirus, and Cordons Sanitaires: Migrant Workers and the Use of Public Health Measures to Define the Nation.卡塔尔、冠状病毒和隔离区：移民工人和使用公共卫生措施来定义国家。
Med Anthropol Q. 2020 Dec;34(4):561-577. doi: 10.1111/maq.12625. Epub 2020 Dec 4.
3
Primary health care physicians' perspective on COVID-19 pandemic management in Qatar: a web-based survey.卡塔尔初级保健医生对 COVID-19 大流行管理的看法：一项基于网络的调查。
BMJ Open. 2021 Sep 22;11(9):e049456. doi: 10.1136/bmjopen-2021-049456.
4
Protection from previous natural infection compared with mRNA vaccination against SARS-CoV-2 infection and severe COVID-19 in Qatar: a retrospective cohort study.与 SARS-CoV-2 感染和卡塔尔严重 COVID-19 相比，先前自然感染的保护作用：一项回顾性队列研究。
Lancet Microbe. 2022 Dec;3(12):e944-e955. doi: 10.1016/S2666-5247(22)00287-7. Epub 2022 Nov 11.
5
COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar.COVID-19 风险评分作为公共卫生工具指导有针对性检测：在卡塔尔的一项示范研究。
PLoS One. 2022 Jul 19;17(7):e0271324. doi: 10.1371/journal.pone.0271324. eCollection 2022.
6
Myths, misconceptions, and hesitancy in people residing in Qatar toward mRNA COVID-19 vaccines: An experience exchange from Qatar University health center.卡塔尔居民对新冠mRNA疫苗的误解、错误观念及犹豫态度：来自卡塔尔大学健康中心的经验交流
Qatar Med J. 2022 Mar 30;2022(2):20. doi: 10.5339/qmj.2022.fqac.20. eCollection 2022.
7
Key Lessons from COVID-19: A Narrative Review Describing Qatar's Multifactorial Approach in Executing a Vaccination Campaign.新冠疫情的关键经验教训：一篇叙述性综述，描述卡塔尔开展疫苗接种运动的多因素方法。
Vaccines (Basel). 2023 May 6;11(5):953. doi: 10.3390/vaccines11050953.
8
Clinical, social and ethical aspects of HIV-1 infections in an Arab Gulf State.阿拉伯海湾国家中HIV-1感染的临床、社会及伦理方面
J Trop Med Hyg. 1992 Apr;95(2):128-31.
9
Evidence of community pharmacists' response preparedness during COVID-19 public health crisis: A cross-sectional study.社区药剂师应对 COVID-19 公共卫生危机的准备情况的证据：一项横断面研究。
J Infect Dev Ctries. 2021 Jan 31;15(1):40-50. doi: 10.3855/jidc.13847.
10
Understanding the epidemiological characteristics of the primary healthcare corporation-based COVID-19 swabbed persons in Qatar, 2020.了解2020年卡塔尔以初级医疗保健机构为基础的新冠病毒咽拭子采样人群的流行病学特征。
Qatar Med J. 2022 Jul 11;2022(3):23. doi: 10.5339/qmj.2022.23. eCollection 2022.

引用本文的文献

1
Longitudinal cellular and humoral immune responses following COVID-19 BNT162b2-mRNA-based booster vaccination of craft and manual workers in Qatar.卡塔尔手工艺和体力劳动者接种基于BNT162b2 mRNA的新冠病毒加强疫苗后的纵向细胞免疫和体液免疫反应
Front Immunol. 2025 Mar 27;16:1557426. doi: 10.3389/fimmu.2025.1557426. eCollection 2025.
2
From past to present: Exploring COVID-19 in Qatar's hemodialysis population across Omicron dominant and pre-Omicron periods.从过去到现在：探索卡塔尔血液透析人群中奥密克戎主导和奥密克戎前时期的 COVID-19 情况。
PLoS One. 2023 Sep 14;18(9):e0291266. doi: 10.1371/journal.pone.0291266. eCollection 2023.
3

本文引用的文献

1
Coronavirus breakthrough: dexamethasone is first drug shown to save lives.冠状病毒研究突破：地塞米松是首个被证明能挽救生命的药物。
Nature. 2020 Jun;582(7813):469. doi: 10.1038/d41586-020-01824-5.
2
Remdesivir for the Treatment of Covid-19 - Final Report.瑞德西韦治疗 COVID-19 的疗效 - 最终报告。
N Engl J Med. 2020 Nov 5;383(19):1813-1826. doi: 10.1056/NEJMoa2007764. Epub 2020 Oct 8.
3
Favipiravir, an antiviral for COVID-19?法匹拉韦，一种用于治疗新冠肺炎的抗病毒药物？
The Art of the Editorial.
社论的艺术
Nepal J Epidemiol. 2022 Mar 31;12(1):1135-1138. doi: 10.3126/nje.v12i1.43104. eCollection 2022 Mar.
J Antimicrob Chemother. 2020 Jul 1;75(7):2013-2014. doi: 10.1093/jac/dkaa171.
4
Should azithromycin be used to treat COVID-19? A rapid review.阿奇霉素是否应用于治疗新型冠状病毒肺炎？一项快速综述。
BJGP Open. 2020 Jun 23;4(2). doi: 10.3399/bjgpopen20X101094. Print 2020.
5
Remdesivir in the treatment of coronavirus disease 2019 (COVID-19): a simplified summary.瑞德西韦治疗2019冠状病毒病（COVID-19）：简要概述。
J Biomol Struct Dyn. 2021 Jul;39(10):3787-3792. doi: 10.1080/07391102.2020.1767691. Epub 2020 May 20.
6
Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A retrospective analysis of 1061 cases in Marseille, France.羟氯喹和阿奇霉素联合治疗 COVID-19 患者：法国马赛 1061 例回顾性分析。
Travel Med Infect Dis. 2020 May-Jun;35:101738. doi: 10.1016/j.tmaid.2020.101738. Epub 2020 May 5.
7
Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.羟氯喹治疗 COVID-19 住院患者的观察性研究。
N Engl J Med. 2020 Jun 18;382(25):2411-2418. doi: 10.1056/NEJMoa2012410. Epub 2020 May 7.
8
Gene of the month: the 2019-nCoV/SARS-CoV-2 novel coronavirus spike protein.本月基因：2019-nCoV/SARS-CoV-2 新型冠状病毒刺突蛋白。
J Clin Pathol. 2020 Jul;73(7):366-369. doi: 10.1136/jclinpath-2020-206658. Epub 2020 May 6.
9
A Rapid Systematic Review of Clinical Trials Utilizing Chloroquine and Hydroxychloroquine as a Treatment for COVID-19.一项利用氯喹和羟氯喹治疗 COVID-19 的临床试验的快速系统评价。
Acad Emerg Med. 2020 Jun;27(6):493-504. doi: 10.1111/acem.14005. Epub 2020 May 29.
10
Remdesivir in covid-19.瑞德西韦用于治疗新冠病毒肺炎
BMJ. 2020 Apr 22;369:m1610. doi: 10.1136/bmj.m1610.